User profiles for "author:Ka Hou Christien Li"
Ka Hou Christien LiInternal medicine doctor, Oxford University Hospital Trust Verified email at ouh.nhs.uk Cited by 1157 |
[HTML][HTML] Mouse models of atherosclerosis: a historical perspective and recent advances
YT Lee, HY Lin, YWF Chan, KHC Li, OTL To… - Lipids in health and …, 2017 - Springer
Atherosclerosis represents a significant cause of morbidity and mortality in both the
developed and developing countries. Animal models of atherosclerosis have served as …
developed and developing countries. Animal models of atherosclerosis have served as …
[HTML][HTML] The current state of mobile phone apps for monitoring heart rate, heart rate variability, and atrial fibrillation: narrative review
KHC Li, FA White, T Tipoe, T Liu… - JMIR mHealth and …, 2019 - mhealth.jmir.org
Background: Mobile phone apps capable of monitoring arrhythmias and heart rate (HR) are
increasingly used for screening, diagnosis, and monitoring of HR and rhythm disorders such …
increasingly used for screening, diagnosis, and monitoring of HR and rhythm disorders such …
[HTML][HTML] Protective effects of sodium-glucose transporter 2 inhibitors on atrial fibrillation and atrial flutter: a systematic review and meta-analysis of randomized placebo …
D Li, Y Liu, TH Hidru, X Yang, Y Wang… - Frontiers in …, 2021 - frontiersin.org
Background Hyperglycemia is associated with an increased risk of developing atrial
fibrillation (AF) and atrial flutter (AFL). Sodium-glucose transporter 2 inhibitors (SGLT2i) …
fibrillation (AF) and atrial flutter (AFL). Sodium-glucose transporter 2 inhibitors (SGLT2i) …
Comparative cardiovascular risk in users versus non-users of xanthine oxidase inhibitors and febuxostat versus allopurinol users
Objectives The aim of this study is to determine major adverse cardiovascular events
(MACE) and all-cause mortality comparing between xanthine oxidase inhibitors (XOIs) and …
(MACE) and all-cause mortality comparing between xanthine oxidase inhibitors (XOIs) and …
[HTML][HTML] Brugada syndrome: A comprehensive review of pathophysiological mechanisms and risk stratification strategies
Brugada syndrome (BrS) is an inherited ion channel channelopathy predisposing to
ventricular arrhythmias and sudden cardiac death. Originally believed to be predominantly …
ventricular arrhythmias and sudden cardiac death. Originally believed to be predominantly …
[HTML][HTML] The role of 3D printing in anatomy education and surgical training: A narrative review
This article was migrated. The article was marked as recommended. Recent expansions in
the development and availability of threedimensional printing (3Dp) have led to the uptake …
the development and availability of threedimensional printing (3Dp) have led to the uptake …
Territory-wide cohort study of Brugada syndrome in Hong Kong: predictors of long-term outcomes using random survival forests and non-negative matrix factorisation
Objectives Brugada syndrome (BrS) is an ion channelopathy that predisposes affected
patients to spontaneous ventricular tachycardia/fibrillation (VT/VF) and sudden cardiac …
patients to spontaneous ventricular tachycardia/fibrillation (VT/VF) and sudden cardiac …
Multi‐modality machine learning approach for risk stratification in heart failure with left ventricular ejection fraction≤ 45%
Aims Heart failure (HF) involves complex remodelling leading to electrical and mechanical
dysfunction. We hypothesized that machine learning approaches incorporating data …
dysfunction. We hypothesized that machine learning approaches incorporating data …
[HTML][HTML] Diagnostic and prognostic value of serum C-reactive protein in heart failure with preserved ejection fraction: a systematic review and meta-analysis
I Lakhani, MV Wong, JKF Hung, M Gong, KB Waleed… - Heart failure …, 2021 - Springer
Heart failure (HF) is a major epidemic with rising morbidity and mortality rates that encumber
global healthcare systems. While some studies have demonstrated the value of CRP in …
global healthcare systems. While some studies have demonstrated the value of CRP in …
[HTML][HTML] Soluble suppression of tumorigenicity 2 (sST2) for predicting disease severity or mortality outcomes in cardiovascular diseases: A systematic review and meta …
C Ip, KS Luk, VLC Yuen, L Chiang, CK Chan, K Ho… - IJC Heart & …, 2021 - Elsevier
Objectives Soluble suppression of tumorigenicity 2 (sST2) is a member of the interleukin-1
receptor family. It is raised in various cardiovascular diseases, but its value in predicting …
receptor family. It is raised in various cardiovascular diseases, but its value in predicting …